TotalMarketCap

Bausch Health Companies

BHCNYSE CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.989 B

$7.99 -4.26%

Close of 6 Nov 2026

As of 6 Nov 2026, Bausch Health Companies (BHC) has a market capitalization of $2.99B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$10.3B

#407 by revenue

Earnings

$157.0M

#1101 by earnings

Shares outstanding

374,266,716

Latest filing cover page

P/E ratio

19.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #73Viridian TherapeuticsVRDN$3.24B
  2. #74Telix PharmaceuticalsTLX$3.19B
  3. #75Bausch Health CompaniesBHC$2.99B
  4. #76IDEAYA BiosciencesIDYA$2.97B
  5. #77Vicore Pharma Holding ABVCRE$2.95B

What if Bausch Health Companies were worth as much as…

Open the what-if tool →

Gold $28.2T

$75,445.86

Per share 9,448× higher

Bitcoin $1.53T

$4,082.24

Per share 511× higher

Apple $5.02T

$13,401.63

Per share 1,678× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Bausch Health Companies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.